THE PREVALENCE OF DEPRESSION AND ASSOCIATED FACTORS AMONG OLDER ADULT OUTPATIENTS AT THE GERIATRICS CLINIC

Ngọc Hoành Mỹ Tiên Nguyễn1,2, , Thị Cẩm Nhung Lương1, Lê Quỳnh Như Võ3, Hà Ngọc Thể Thân1,2
1 Trường Y – Đại học Y Dược TPHCM
2 Bệnh viện Đại học Y Dược TPHCM
3 Bệnh viện Đà Nẵng

Main Article Content

Abstract

Background: Depression is the most common mental disorder among older adults, and is a leading cause of functional impairment, reduced quality of life, and increased risk of mortality. Despite its significant impacts, depression among older adults remains under-recognized and undertreated, with a lack of timely and appropriate interventions.


Objectives: This study aimed to determine the prevalence of depression and identify associated factors among older adults aged 60 years and above attending the Geriatrics Outpatient Clinic at University Medical Center Ho Chi Minh City.


Methods: A descriptive cross-sectional study was conducted on older adults (≥ 60 years old) undergoing health examinations at the Geriatrics Outpatient Clinic, University Medical Center Ho Chi Minh City, from October 2024 to March 2025. Depression screening was performed using the GDS-15, with a cut-off score of  ≥ 6 to define depression. Multivariate logistic regression analysis was utilized to evaluate factors independently associated with depression.


Results: The study included 322 older adults. The prevalence of depression based on GDS-15 was 39.4%. Independent factors significantly associated with depression included overweight (OR = 0.19; KTC 95% 0.07 – 0.57; p = 0.003), obesity (OR = 0.33; KTC 95% 0.11 – 0.95; p = 0.040), financial difficulty (OR = 2.96; KTC 95%: 1.45 – 6.01; p = 0.003), frailty status according to CFS (OR = 2.27; KTC 95%: 1.02 – 5.14; p = 0.048), polypharmacy (OR = 2.54; KTC 95%: 1.06 – 6.09; p = 0.037), chronic kidney disease (OR = 3.85; KTC 95%: 1.48 – 9.98; p = 0.005).


Conclusions: The prevalence of depression among elderly outpatients at the Geriatrics Clinic based on GDS-15 was 39.4%. BMI, financial status, frailty, polypharmacy, and chronic kidney disease were significant independent factors associated with depression. These findings highlight the need for comprehensive depression screening and targeted interventions addressing some chronic medical conditions to improve mental health outcomes in the older population.

Article Details

References

1. Zenebe Y, Akele B, W/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55. doi:10.1186/s12991-021-00375-x
2. Prakash O, Gupta LN, Singh VB, Nagarajarao G. Applicability of 15-item Geriatric Depression Scale to detect depression in elderly medical outpatients. Asian J Psychiatr. 2009;2(2):63-65. doi:10.1016/j.ajp.2009.04.005
3. Vo PBN, Phan NBT, Le TKC, Nguyen PV. Ty le thieu co (sarcopenia) va cac yeu to lien quan o nguoi cao tuoi den kham tai phong kham Lao khoa – Benh vien Dai hoc Y Duoc Thanh pho Ho Chi Minh. Tap Chi Y Hoc Viet Nam [Internet]. 2024 [cited 2025 Jun 17];543(2). doi:10.51298/vmj.v543i2.11448
4. Huân NT, Tuyết HT, Hai NVB. Trầm cảm ở người bệnh cao tuổi nội trú có bệnh tim mạch: Tỷ lệ và yếu tố liên quan. Journal of 108 - Clinical Medicine and Pharmacy. Published online February 5, 2024. doi:10.52389/ydls.v19i1.2110
5. Yu M, Shi Y, Gu L, Wang W. “Jolly fat” or “sad fat”: a systematic review and meta-analysis of the association between obesity and depression among community-dwelling older adults. Aging Ment Health. 2022;26(1):13-25. doi:10.1080/13607863.2020.1857687.
6. Trần VL, Nguyễn TMK, Nguyễn NT. Một số yếu tố liên quan với tình trạng trầm cảm ở người bệnh suy dinh dưỡng cao tuổi. Tạp chí Y học Việt Nam. 2024;538(2). doi:10.51298/vmj.v538i2.9460
7. Duong Thi Ngoc L. Prevalence of depression, cognition impairment, nutrition and related factors in patients with chronic kidney disease stage 3 - 5. Journal of Medicine and Pharmacy. Published online November 2022:55-61. doi:10.34071/jmp.2022.6.7
8. Gong S, Deng F. Renin-angiotensin system: the underlying mechanisms and promising therapeutical target for depression and anxiety. Front Pharmacol. 2022;13:1004361.